GO:1903716 guanine transmembrane transport: Transport Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1903716 (guanine transmembrane transport) is the biological process that moves the nucleobase guanine across a lipid bilayer.
Transporters of the nucleobase transporter family, such as Arabidopsis AZG1, provide structural and mechanistic paradigms for guanine permeation and proton-coupled substrate recognition.
Membrane protein insertion and quality control at the endoplasmic reticulum determine whether newly synthesized transporters reach the membrane in a functional state.
Guanine transport is functionally coupled to nucleotide pools, nucleic acid metabolism, and purine salvage, and its perturbation can alter RNA and DNA precursor availability.
Viral infection and inflammatory signaling can remodel nucleobase transport and purine metabolism, making GO:1903716 relevant to host-pathogen and immune studies.
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate guanine transporters in human cells.

Description

Guanine transmembrane transport (GO:1903716) is defined as the process in which guanine is transported across a membrane. Guanine is one of the four canonical nucleobases used in RNA and DNA, and its availability within cells depends on both de novo purine synthesis and salvage pathways that require membrane translocation steps. The process is therefore a point of control over intracellular purine pools and, indirectly, over nucleic acid synthesis and signaling. Structural and functional work on nucleobase transporters has begun to define how a substrate such as guanine is recognized and moved across a membrane. In parallel, studies of membrane protein biogenesis show that transporter function depends on correct insertion, folding, and trafficking through the endoplasmic reticulum. Together, these findings make GO:1903716 a tractable process for genetic and biochemical dissection in both plant and animal systems.

guanine transmembrane transport At A Glance

GO ID GO:1903716
GO term guanine transmembrane transport
Ontology biological_process
Synonym none
Definition The process in which guanine is transported across a membrane.
Major function Movement of the purine nucleobase guanine across a lipid bilayer, linking extracellular or organellar guanine to intracellular purine metabolism.
Substrate Guanine (purine nucleobase)
Cellular context Plasma membrane and organellar membranes; dependent on membrane protein biogenesis and trafficking
Related processes Purine salvage, nucleotide biosynthesis, nucleic acid metabolism
Representative transporter AZG1, a cytokinin/nucleobase transporter with structural and mechanistic data

What Is GO:1903716?

GO:1903716 describes the directed movement of guanine, a purine nucleobase, across a biological membrane. It covers the step or steps by which guanine is transferred from one side of a lipid bilayer to the other, whether by a dedicated transporter, a permease, or a channel-like protein. The term is a biological process and does not by itself specify the molecular function of the protein that performs the transport; that function is annotated separately. Because guanine is a precursor for guanine nucleotides, this transport step connects extracellular or organellar guanine pools to cytoplasmic and nuclear nucleotide metabolism.

Why Is guanine transmembrane transport Important in Cell Biology?

Guanine transmembrane transport matters because it sits at the interface between environmental or organellar guanine and the intracellular purine pool that supports RNA, DNA, and GTP-dependent signaling. When this transport step is altered, cells can experience shifts in nucleotide availability that affect proliferation, stress responses, and viral replication. Because transporter activity depends on membrane protein insertion and quality control, defects in biogenesis can phenocopy transport loss even when the transporter gene itself is intact. Studying GO:1903716 therefore requires combining transport assays with genetic perturbation and cell biological readouts.
Controls intracellular guanine availability for purine salvage and nucleotide synthesis.
Influences RNA and DNA precursor pools, with downstream effects on gene expression and proliferation.
Provides a mechanistic entry point for studying nucleobase transporter structure and substrate specificity.
Connects to membrane protein biogenesis, since transporters must be correctly inserted and folded to function.
Relevant to host-pathogen interactions, as viral infection can remodel nucleobase and purine metabolism.
Relevant to inflammatory signaling, which can alter epithelial transport and metabolic programs.
Supports development of CRISPR models to test causality of candidate transporter genes.
Offers a defined biochemical activity for high-throughput transport and inhibitor screens.
Links organellar and plasma membrane transport to whole-cell metabolic state.
Provides a framework for comparative studies across plant and animal nucleobase transporters.

What Happens During guanine transmembrane transport?

Substrate recognition at the membrane
In simple terms: The transporter first has to recognize guanine and bind it on one side of the membrane.
Guanine transmembrane transport begins with substrate recognition by a membrane protein that can discriminate guanine from related purines and pyrimidines. Structural studies of the Arabidopsis nucleobase transporter AZG1 have revealed how a transporter can coordinate a nucleobase substrate within a defined binding pocket, providing a template for understanding guanine recognition. This step is selective and depends on the chemical complementarity between the substrate and the binding site.
Conformational cycling and translocation
In simple terms: After binding, the transporter changes shape to carry guanine across the membrane.
Once guanine is bound, the transporter undergoes conformational changes that expose the substrate to the opposite side of the membrane. Mechanistic and structural analysis of AZG1 supports an alternating-access type cycle in which substrate binding and release are coupled to protein motion. This translocation step is the core of GO:1903716 and determines the rate and direction of guanine movement.
Coupling to proton or ion gradients
In simple terms: Many nucleobase transporters use a proton or ion gradient as an energy source to move guanine.
Nucleobase transport is often coupled to proton or ion gradients, which provide the driving force for substrate accumulation. The AZG1 structure and mechanism indicate that nucleobase transport can be linked to proton coupling, a principle that informs how guanine transport may be energized in different systems. This coupling distinguishes active transport from passive permeation and shapes the directionality of guanine flux.
Membrane insertion and quality control
In simple terms: Before a transporter can work, it must be correctly inserted into the membrane and pass quality checks.
Functional guanine transport requires that the transporter protein be properly inserted into the endoplasmic reticulum membrane and routed to its final destination. Reviews of membrane protein insertion at the endoplasmic reticulum describe the machinery and quality-control steps that ensure only correctly folded proteins reach the membrane. Failure at this stage reduces the number of active transporters at the membrane and can phenocopy loss of transport activity.
Integration with purine metabolism
In simple terms: Once inside, guanine feeds into the cell's purine and nucleotide pools.
Transported guanine enters intracellular purine metabolism, where it can be salvaged into guanine nucleotides and contribute to RNA and DNA synthesis. RNA profiling studies of virus-infected neural cells show that infection can reshape host metabolic and transport programs, including purine-related pathways. This integration means that changes in guanine transmembrane transport can propagate to nucleotide pools and nucleic acid metabolism.

Key Genes Involved in GO:1903716 guanine transmembrane transport

The following genes and proteins are experimentally or mechanistically linked to nucleobase transport, membrane protein biogenesis, or purine-related cellular processes relevant to GO:1903716.
GeneMajor RoleResearch Relevance
AZG1Arabidopsis nucleobase/cytokinin transporter with structural and mechanistic dataProvides a structural template for substrate recognition and transport cycling in nucleobase transporters
RAB-8Small GTPase involved in membrane trafficking and unconventional protein secretionIllustrates how trafficking machinery can influence delivery of membrane proteins
RAB-11Small GTPase regulating vesicle trafficking to membranesCoordinates with RAB-8 in membrane protein delivery pathways relevant to transporter localization
RAB7Late endosomal GTPase involved in autolysosome and SNARE complex regulationShows how Rab-dependent trafficking can affect membrane protein fate
HOPS complex componentsTethering complex required for SNARE assembly and membrane fusionLinks membrane fusion machinery to delivery of membrane proteins
SNARE proteinsMediate membrane fusion eventsRequired for trafficking of transporters to their target membranes
ER insertion machinery componentsFacilitate membrane protein insertion at the endoplasmic reticulumDetermine whether newly synthesized transporters fold and reach the membrane
ER quality control factorsRecognize and degrade misfolded membrane proteinsModulate the steady-state level of functional transporters
Purine salvage pathway enzymesConvert guanine into guanine nucleotidesConnect transported guanine to nucleotide pools and nucleic acid synthesis
Nucleobase transporter family membersTransport nucleobases across membranesCandidate genes for functional testing of guanine transport
Cytokinin transport machineryTransports cytokinin and related nucleobase-like substratesProvides comparative insight into substrate specificity of nucleobase transporters
Viral effectors that remodel host metabolismAlter host transport and metabolic programs during infectionLink guanine transport to host-pathogen interactions
Inflammatory signaling mediatorsModify epithelial transport and metabolic gene expressionProvide context for regulation of nucleobase transport in inflammation
Placental epigenetic regulatorsInfluence gene expression programs including transport-related genesIllustrate tissue-specific regulation of transport gene expression
Autophagy-related proteinsControl membrane trafficking and degradationCan influence transporter turnover and localization
Secretory pathway componentsRegulate delivery of proteins to the plasma membraneDetermine surface expression of transporters
Membrane protein chaperonesAssist folding of membrane proteinsSupport functional maturation of transporters
Nucleotide metabolism enzymesSynthesize and interconvert purine nucleotidesDetermine the metabolic fate of transported guanine

How Is guanine transmembrane transport Regulated?

Guanine transmembrane transport is regulated at multiple levels. Transcriptional and post-transcriptional programs can alter the abundance of transporter mRNAs, as suggested by RNA profiling studies showing infection-dependent changes in host transport and metabolic gene expression. Inflammatory signaling can also modify epithelial transport and metabolic gene expression, providing a context in which nucleobase transport may be adjusted. At the protein level, membrane trafficking pathways involving RAB-8, RAB-11, RAB7, HOPS, and SNARE complexes control the delivery and turnover of membrane proteins, thereby influencing how much transporter reaches the membrane. Finally, endoplasmic reticulum insertion and quality-control machinery determines whether newly synthesized transporters fold correctly and avoid degradation.

guanine transmembrane transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
AZG1Nucleobase transport mechanism and substrate specificityHeterologous expression and transport assays in mammalian cells
RAB-8Membrane trafficking and protein secretionKnockout or knockdown in cultured cells followed by transporter localization assays
RAB7Autolysosome and SNARE-dependent traffickingKnockout cells to test transporter delivery and turnover
ER insertion machinery componentsMembrane protein biogenesis and quality controlKnockout or point-mutation models to assess transporter maturation
Purine salvage enzymesNucleotide metabolism and nucleic acid synthesisMetabolic labeling and nucleotide pool analysis after transporter perturbation
Infection and host metabolic remodeling
Viral infection can reprogram host cell metabolism and transport, as shown by integrative RNA profiling of TBEV-infected neurons and astrocytes, which identified potential pathogenic effectors and altered host pathways. Because guanine transmembrane transport feeds purine pools, infection-driven changes in transport could influence viral replication and host cell survival.
Inflammatory airway disease
Inflammatory signaling in human bronchial epithelia can alter transport and metabolic gene expression, as demonstrated in studies of formoterol-induced pro-inflammatory action. Such changes may affect nucleobase availability and epithelial function, linking GO:1903716 to airway inflammatory biology.
Membrane trafficking disorders
Defects in RAB-8, RAB-11, RAB7, HOPS, or SNARE-dependent trafficking can impair delivery of membrane proteins, including transporters, to their target membranes. These trafficking defects can reduce functional guanine transport even when the transporter gene is normal, contributing to cellular metabolic stress.
Developmental and placental biology
Epigenetic studies of placental DNA methylation related to gestational age have identified sex-based differences in methylation profiles, which can influence expression of transport and metabolic genes. Such regulation may affect nucleobase transport during development, although direct links to guanine transport require further study.

From guanine transmembrane transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Is a candidate gene required for guanine transport?CRISPR knockout of the candidate transporter followed by transport assay
Does a specific residue determine substrate specificity?Point-mutation knock-in of the predicted binding-site residue
Does tagging the transporter affect localization?Knock-in of an epitope or fluorescent tag at the endogenous locus
Does overexpression increase guanine uptake?Stable or transient overexpression of the transporter in a recipient cell line
Does trafficking machinery control transporter surface levels?Knockout of RAB-8, RAB-11, RAB7, or SNARE components with imaging of tagged transporter
Does infection alter guanine transport gene expression?RNA profiling of infected versus control cells

How to Study the guanine transmembrane transport Process

MethodWhat It MeasuresTypical Application
Radiolabeled guanine uptakeRate and extent of guanine transport across the membraneFunctional validation of candidate transporters
Fluorescent substrate transport assayReal-time substrate flux in live cellsScreening of transporter variants and inhibitors
RNA sequencingChanges in transporter and metabolic gene expressionInfection or inflammation studies
Fluorescence microscopy of tagged transportersSubcellular localization and surface deliveryTrafficking perturbation experiments
Membrane insertion and folding assaysEfficiency of endoplasmic reticulum insertion and quality controlAnalysis of transporter biogenesis
Nucleotide pool analysisIntracellular guanine nucleotide levelsLinking transport to purine metabolism
CRISPR knockout followed by transport assayCausal requirement of a gene for guanine transportCandidate gene validation
Epigenetic profilingDNA methylation at transport gene lociTissue-specific regulation studies
Transport assays
Direct measurement of guanine uptake across membranes can be performed using radiolabeled or fluorescent guanine analogs in cells expressing candidate transporters. Such assays, informed by structural and mechanistic studies of nucleobase transporters like AZG1, define whether a gene product can carry guanine and how efficiently.
RNA profiling and transcriptomics
RNA sequencing and integrative RNA profiling can reveal changes in transporter and metabolic gene expression under conditions such as viral infection. These approaches identify candidate transport genes whose expression correlates with altered purine metabolism.
Imaging of membrane protein localization
Fluorescence imaging of tagged transporters, combined with perturbation of RAB-8, RAB-11, RAB7, HOPS, or SNARE components, can determine how trafficking pathways control transporter delivery to the membrane. This connects transport activity to membrane protein biogenesis and trafficking.
Membrane protein biogenesis assays
Biochemical and cell-based assays of endoplasmic reticulum insertion and quality control can assess whether a transporter folds correctly and escapes degradation. These methods complement transport assays by distinguishing folding defects from intrinsic transport defects.

How CRISPR Can Be Used to Study GO:1903716 guanine transmembrane transport

Knockout

CRISPR knockout of a candidate guanine transporter gene provides a direct test of whether that gene is required for guanine transmembrane transport. Loss-of-function clones can be assayed for guanine uptake and for downstream changes in nucleotide pools, using principles established for nucleobase transporter characterization. Knockout of trafficking genes such as RAB-8, RAB-11, or RAB7 can additionally reveal whether transporter delivery to the membrane depends on specific trafficking pathways.

Point Mutation

Point-mutation knock-in allows precise testing of residues predicted to mediate substrate binding or conformational cycling. Structural studies of nucleobase transporters such as AZG1 identify candidate residues for such experiments, and point mutants can be assayed for altered guanine transport activity. This approach distinguishes substrate recognition from membrane insertion defects.

Knock-in

Knock-in of an epitope or fluorescent tag at the endogenous transporter locus enables tracking of the protein's localization and trafficking without overexpression artifacts. This is particularly useful for studying membrane protein biogenesis and delivery, where endoplasmic reticulum insertion and quality control determine functional surface expression. Tagged knock-in lines can be combined with trafficking perturbations to map the route to the membrane.

Overexpression

Overexpression of a candidate transporter in a recipient cell line can be used to test whether the protein is sufficient to increase guanine uptake. This approach is widely used in transporter characterization and can be combined with mutagenesis to dissect mechanism. Overexpression models also allow biochemical purification and structural studies of the transporter.

How EDITGENE Supports guanine transmembrane transport Research

Researchers studying guanine transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in guanine uptake, how specific residues contribute to substrate recognition, and where the transporter localizes within the cell. Answering these questions requires precise genetic models that can isolate transport function from membrane biogenesis and trafficking effects. EDITGENE provides the full range of CRISPR cell models needed to move from candidate gene to validated mechanism.
Contact EDITGENE today to design your custom CRISPR model for guanine transmembrane transport research.

Frequently Asked Questions About guanine transmembrane transport

GO:1903716 is the biological process in which the nucleobase guanine is transported across a membrane, connecting extracellular or organellar guanine to intracellular purine metabolism.
Genes encoding nucleobase transporters such as AZG1 provide structural and mechanistic paradigms, while trafficking genes including RAB-8, RAB-11, and RAB7 influence delivery of transporters to the membrane.
Transported guanine feeds purine salvage and nucleotide synthesis, influencing RNA and DNA precursor pools and cellular metabolism.
Transporters bind guanine and undergo conformational cycling, often coupled to proton or ion gradients, to move the substrate across the lipid bilayer.
Transporters must be correctly inserted and folded at the endoplasmic reticulum to reach the membrane in a functional state; quality control defects can reduce transport activity.
RNA profiling of infected neural cells shows that infection remodels host transport and metabolic gene expression, which can influence purine-related pathways.
Knockout of a candidate transporter gene allows direct testing of whether the gene is required for guanine uptake and for downstream nucleotide pool changes.
Radiolabeled or fluorescent guanine uptake assays, combined with RNA sequencing and imaging of tagged transporters, are commonly used to measure transport and localization.
Inflammatory signaling can alter epithelial transport and metabolic gene expression, providing a context in which nucleobase transport may be regulated.
Heterologous expression systems, CRISPR knockout and knock-in cell lines, and trafficking perturbation models are used to dissect guanine transport mechanism and regulation.

Conclusion

Guanine transmembrane transport (GO:1903716) is a defined biological process that links membrane transport to purine metabolism and nucleic acid synthesis. Structural and mechanistic studies of nucleobase transporters such as AZG1 provide a framework for understanding substrate recognition and translocation, while membrane protein biogenesis and trafficking pathways determine whether transporters function at the membrane. Because infection and inflammation can remodel transport gene expression, this process is relevant to host-pathogen and immune biology. CRISPR-based knockout, point-mutation, knock-in, and overexpression models offer a rigorous path to test causality and mechanism in this pathway.

References

  1. 1. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
  2. 2. Li X et al.. 2024. Coordination of RAB-8 and RAB-11 during unconventional protein secretion.. J Cell Biol 223(2) PMID: 38019180
  3. 4. Chen M et al.. 2026. African swine fever virus I10L protein inhibits autolysosome formation by disrupting RAB7-HOPS complex-dependent SNARE complex assembly.. Autophagy 22(9):2216-2231 PMID: 42138513
  4. 5. Bulka CM et al.. 2023. Sex-based differences in placental DNA methylation profiles related to gestational age: an NIH ECHO meta-analysis.. Epigenetics 18(1):2179726 PMID: 36840948
  5. 6. Liu XJ et al.. 2023. Pro-inflammatory action of formoterol in human bronchial epithelia.. Mol Immunol 160:95-102 PMID: 37413911
  6. 7. Xu L et al.. 2024. Structures and mechanisms of the Arabidopsis cytokinin transporter AZG1.. Nat Plants 10(1):180-191 PMID: 38172575
  7. 8. Shao S et al.. 2011. Membrane protein insertion at the endoplasmic reticulum.. Annu Rev Cell Dev Biol 27:25-56 PMID: 21801011
Contact Us
*
*
*
*
How did you hear about us: